Name Description
lenvatinib a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4)
TCRDv4.6.0
DisGeNET
CLINVAR
DrugCentral Indication
DrugCentral
lenvatinib